CXCR2 Activated JAK3/STAT3 Signaling Pathway Exacerbating Hepatotoxicity Associated with Tacrolimus
Introduction Tacrolimus was approved in the United States in April 1994 for the prevention of organ rejection after liver transplantation.1 In addition, it could be used for kidney transplantation,2 heart transplantation,3 lung transplantation,4 …